Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV631
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,269
Award facts
- Contract value 100% obligated
- $10,268.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $10,268.84 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 16, 2026, for Trulicity 0.75 mg/0.5 mL pens. The award, which carries an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
The delivery order represents a continuation of AmerisourceBergen's established role as a critical federal medical supplier. Trulicity, a diabetes medication, falls within the company's extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices that it supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded nature of this transaction and the company's substantial IDC demonstrate AmerisourceBergen's capability to meet federal procurement requirements and efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FV631?
SPE2DR26FV631 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FV631 worth?
The government has obligated $10,269 on SPE2DR26FV631.
Is contract SPE2DR26FV631 an order under another contract?
Yes. SPE2DR26FV631 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV631 competed?
The extent of competition for SPE2DR26FV631 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award